Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands.
Catheter Cardiovasc Interv. 2011 Jul 1;78(1):14-9. doi: 10.1002/ccd.22932.
The objective of this study was to compare the efficacy and long-term clinical outcome of manual thrombus aspiration with the Export catheter (Medtronic, Minneapolis, MN) versus mechanical thrombus cutting/aspiration with the X-sizer system (eV3, White Bear Lake, MN) in primary percutaneous coronary intervention (PPCI).
In PPCI for acute ST-segment elevation myocardial infarction (STEMI), markers of myocardial reperfusion are improved with adjunctive thrombectomy. Previous studies of different devices showed a variability in performance, suitability, and short-term clinical outcome. In current literature, no direct comparison is available.
We prospectively randomized 201 patients admitted for PPCI for STEMI to either the Export catheter or the X-sizer prior to stent deployment. Technical success in advancing to and across the lesion, improvement of flow, reduction of thrombus, and the effect on ST-segment resolution were examined. The primary endpoint of the follow-up study was the combined endpoint of cardiac death, recurrent myocardial infarction (MI), or target-vessel revascularization (TVR) at 3 years.
Although the Export catheter was more successfully deployed, other procedural parameters were similar with a trend toward better ST-segment resolution (56.6% vs. 44%; P = 0.06) as compared to the X-sizer system. The occurrence of the primary clinical endpoint at 3 years was 22.2% and 18.6%, respectively (HR 1.20; 95% CI 0.65-2.22; P = 0.35).
Despite shorter procedural times, better lesion crossing, and fewer complications, both surrogate endpoints as well as 3-year clinical follow-up were similar with the use of the Export catheter as compared to the X-sizer system.
本研究旨在比较直接经皮冠状动脉介入治疗(PPCI)中手动血栓抽吸与 Export 导管(美敦力,明尼苏达州明尼阿波利斯)和机械血栓切割/抽吸与 X-sizer 系统(eV3,明尼苏达州白湖)的疗效和长期临床结果。
在急性 ST 段抬高型心肌梗死(STEMI)的 PPCI 中,辅助血栓切除术可改善心肌再灌注标志物。先前不同设备的研究显示出性能、适用性和短期临床结果的差异。目前文献中尚无直接比较。
我们前瞻性地随机将 201 例因 STEMI 而行 PPCI 的患者分为 Export 导管组或 X-sizer 组,在支架置入前使用相应装置。检查导丝进入和穿过病变、血流改善、血栓减少以及对 ST 段分辨率的影响等技术成功情况。随访研究的主要终点是 3 年内的心脏死亡、复发性心肌梗死(MI)或靶血管血运重建(TVR)的复合终点。
尽管 Export 导管的植入更为成功,但其他程序参数相似,X-sizer 系统的 ST 段分辨率改善趋势更好(56.6% vs. 44%;P=0.06)。3 年时主要临床终点的发生率分别为 22.2%和 18.6%(HR 1.20;95%CI 0.65-2.22;P=0.35)。
尽管在操作时间更短、病变穿透更好、并发症更少的情况下,与 X-sizer 系统相比,使用 Export 导管的替代终点和 3 年临床随访结果相似。